CARDLYTICS, INC. (CDLX)

Every figure this model derived for CDLX, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 69,000 PaymentsToAcquirePropertyPlantAndEquipment 2026-06-30
cash 52,169,000 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 101,071,000 AssetsCurrent 2026-06-30
current liabilities 62,350,000 LiabilitiesCurrent 2026-06-30
equity -16,004,000 StockholdersEquity 2026-06-30
interest expense 10,100,000 InterestExpenseNonoperating 2026-06-30
ocf 532,000 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 179,327,000 Revenues 2026-06-30
sbc 19,117,000 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up CDLX on one particular measure came for.

RatioValue
cash operating margin-26.98
current ratio1.68
current ratio reported1.62
deferred revenue growth-29.29
dilution pct9.84
fcf margin0.26
growth cv3.23
interest cover-8.78
operating margin-49.44
owner earnings margin-10.4
revenue growth-29.82
revenue growth per share-36.11
roic-60.26
rpo growth-45.9
rule of 40-79.26
sbc pct revenue10.66

What to be careful about

What this model itself distrusts about CDLX's figures. Written by the derivation as it ran, not added afterwards.